Status:
COMPLETED
Suicidality and Suicide Attempt Among HIV Patients on Efavirenz-containing Versus Efavirenz-free Antiretroviral Regimens
Lead Sponsor:
Bristol-Myers Squibb
Collaborating Sponsors:
Truven Health Analytics
Conditions:
HIV Infection
Eligibility:
All Genders
12+ years
Brief Summary
The purpose of this study was to compare the frequency of suicidality and suicide attempt among HIV patients starting treatment with Efavirenz and with patients starting treatment with other HIV medic...
Eligibility Criteria
Inclusion
- For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com
- At least 6 months of enrollment before first prescription
- Antiretroviral naive
Exclusion
- No diagnosis of HIV on patient record
- Age \< 12 years
Key Trial Info
Start Date :
April 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
11400 Patients enrolled
Trial Details
Trial ID
NCT02211807
Start Date
April 1 2014
End Date
August 1 2014
Last Update
October 15 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.